Xometry, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated June 9, 2025, details a material financing event for Xometry, Inc. (XMTR). On June 12, 2025, the Company completed a private offering of convertible senior notes. The filing also discloses related hedging transactions and the strategic use of proceeds to refinance existing debt.
Key Financial Metrics and Transaction Details
- Debt Issuance: $250.0 million aggregate principal amount of 0.75% Convertible Senior Notes due 2030 (including a full $25.0 million option exercise).
- Net Proceeds: Approximately $241.2 million after deducting discounts, commissions, and estimated expenses.
- Interest Rate: 0.75% per annum, payable semiannually starting December 15, 2025.
- Maturity Date: June 15, 2030.
- Conversion Terms: Initial conversion price of approximately $47.06 per share (30.0% premium to the $36.20 stock price on June 9, 2025). Initial conversion rate is 21.2495 shares per $1,000 principal amount.
- Capped Call Transactions: Entered into to reduce potential dilution; cost approximately $17.5 million. Cap price set at $63.35 per share (75% premium).
- Debt Repayment: Approximately $216.7 million of net proceeds used to repurchase $201.7 million of 1.00% Convertible Senior Notes due 2027.
- Remaining 2027 Notes: Approximately $85.8 million aggregate principal amount expected to remain outstanding after repurchases.
Material Changes Versus Prior Period
This filing represents a significant change in the Company's capital structure. The issuance of the 2030 Notes and the concurrent repurchase of the 2027 Notes effectively extend the Company's debt maturity profile and reduce the interest rate burden on the repurchased portion of the debt (from 1.00% to 0.75%). The filing does not provide comparative revenue, profit, or cash flow metrics as it is a transaction-specific report rather than a periodic financial statement.
Guidance, Outlook, and Risks
Use of Proceeds: Beyond the debt refinancing, remaining proceeds are designated for working capital, general corporate purposes, potential future repurchases of 2027 Notes, and strategic acquisitions or investments. No specific acquisition agreements are currently in place.
Risks and Contingencies:
- Dilution Risk: While capped call transactions mitigate dilution, up to 6,906,075 shares of Common Stock may be issued upon conversion of the Notes.
- Redemption: The Company may not redeem the Notes prior to June 20, 2028, subject to specific stock price conditions.
- Events of Default: Includes failure to pay interest or principal, failure to convert upon exercise, bankruptcy, and cross-defaults on other indebtedness exceeding $50 million.
- Forward-Looking Statements: The Company notes that expectations regarding the use of proceeds and transaction effects are subject to market risks and uncertainties.
Investor Verification Checklist
- Verify the final settlement of the $201.7 million repurchase of 2027 Notes and confirm the remaining outstanding balance of $85.8 million.
- Monitor the Company's stock price relative to the $47.06 conversion price and the $63.35 cap price to assess potential dilution or cash settlement obligations.
- Review the Indenture (Exhibit 4.1) for specific covenants regarding asset sales, mergers, and fundamental change repurchase rights.
- Confirm the impact of the $17.5 million cost of capped call transactions on the Company's immediate cash position.
- Check for any subsequent filings regarding the "strategic investments or acquisitions" mentioned as a potential use of remaining proceeds.